Wells Fargo’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-238
Closed -$652 6518
2024
Q1
$652 Buy
238
+4
+2% +$11 ﹤0.01% 5845
2023
Q4
$569 Sell
234
-12,598
-98% -$30.6K ﹤0.01% 5909
2023
Q3
$25.9K Sell
12,832
-2
-0% -$4 ﹤0.01% 5132
2023
Q2
$37.9K Sell
12,834
-5,802
-31% -$17.1K ﹤0.01% 5244
2023
Q1
$46.6K Buy
18,636
+6,026
+48% +$15.1K ﹤0.01% 4899
2022
Q4
$40K Sell
12,610
-67
-0.5% -$212 ﹤0.01% 4658
2022
Q3
$37K Sell
12,677
-461
-4% -$1.35K ﹤0.01% 4777
2022
Q2
$40K Sell
13,138
-2,869
-18% -$8.74K ﹤0.01% 4847
2022
Q1
$216K Sell
16,007
-11,223
-41% -$151K ﹤0.01% 4637
2021
Q4
$354K Buy
27,230
+27,130
+27,130% +$353K ﹤0.01% 4600
2021
Q3
$1K Sell
100
-4,478
-98% -$44.8K ﹤0.01% 6314
2021
Q2
$46K Sell
4,578
-4,528
-50% -$45.5K ﹤0.01% 5272
2021
Q1
$167K Sell
9,106
-322
-3% -$5.91K ﹤0.01% 4917
2020
Q4
$324K Buy
+9,428
New +$324K ﹤0.01% 4723